Brii Biosciences Limited (HKG:2137)

Brii Biosciences Revenue

Brii Biosciences had revenue of 34.56M CNY in the half year ending December 31, 2025, with 118.79% growth. This brings the company's revenue in the last twelve months to 34.85M, up 21.12% year-over-year. In the year 2025, Brii Biosciences had annual revenue of 35.55M, down -28.81%.

• Revenue (ttm): 34.85M CNY
• Revenue Growth: +21.12%
• P/S Ratio: 18.48
• Revenue / Employee: 464.68K CNY
• Employees: 75
• Market Cap: 743.46M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.55M	-14.39M	-28.81%
Dec 31, 2024	49.94M	-5.96M	-10.65%
Dec 31, 2023	55.89M	-66.39M	-54.29%
Dec 31, 2022	122.28M	29.74M	32.13%
Dec 31, 2021	92.54M	10.32M	12.56%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 26, 2026

Data Sources Report a data error